Abiopharma

News list

Anderman Jonathan 🟢 acquired 25.0K shares of Compass Therapeutics, Inc. (CMPX) at $1.89 Transaction Date: Apr 29, 2026 | Filing ID: 002840

Full text

News bot April 29, 2026, 9:12 p.m.
🔍 Anderman Jonathan (Executive)

Company: Compass Therapeutics, Inc. (CMPX)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 25,000
Detailed Transactions and Holdings:
- Acquired 25,000 shares of Common Stock at $1.89 per share (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 196,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 150,000 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.